Baseline characteristics and effects of growth hormone therapy over two years in younger and elderly adults with adult onset GH deficiency

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 11, 2006, Pages 4408-4414

  Franco, Celina ^a   Johannsson, Gudmundur ^a   Bengtsson, Bengt Åke ^a   Svensson, Johan ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SOMATOMEDIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; BONE DENSITY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; EXTRACELLULAR FLUID; FEMALE; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPOPITUITARISM; LOW DRUG DOSE; MALE; ONSET AGE; PRIORITY JOURNAL; WAIST HIP RATIO;

EID: 33751545990     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-0887     Document Type: Article

References (30)

1. Corpas E, Harman S, Blackman M 1993 Human growth hormone and human aging. Endocr Rev 14:20-38
2. Lamberts S, Van ben Beld A, Van der Lely A-J 1997 The endocrinology of aging. Science 278:419-424
3. Toogood A, O'Neill P, Shalet S 1996 Beyond the somatopause: growth hormone deficiency in adults over the age of 60 years. J Clin Endocrinol Metab 81:460-465
4. Toogood A, Adams J, O'Neill P, Shalet S 1996 Body composition in growth hormone deficient adults over the age of 60 years. Clin Endocrinol (Oxf) 45:399-405
5. Toogood A, Adams J, O'Neill P, Shalet S 1997 Elderly patients with adult-onset growth hormone deficiency are not osteopenic. J Clin Endocrinol Metab 82:1462-1466
6. Fernholm R, Bramnert M, Hagg E, Hilding A, Baylink D, Mohan S, Thoren M 2000 Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease. J Clin Endocrinol Metab 85:4104-4112
7. De Boer H, Blok G-J, Van Der Veen E 1995 Clinical aspects of growth hormone deficiency in adults. Endocr Rev 16:63-86
8. Carroll P, Christ E, Bengtsson B-Å, Carlsson L, Christiansen JS, Clemmons D, Hintz R, Ho K, Laron Z, Sizonenko P, Sönksen P, Tanaka T, Thorner M 1998 Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. J Clin Endocrinol Metab 83:382-395
9. Drake W, Howell S, Monson J, Shalet S 2001 Optimizing GH therapy in adults and children. Endocr Rev 22:425-450
10. Johannsson G, Sunnerhagen K, Svensson J 2004 Baseline characteristics and the effects of two years of growth hormone (GH) replacement therapy in adults with GH deficiency previously treated for Cushing's disease. Clin Endocrinol (Oxf) 60:550-559
11. Koranyi J, Svensson J, Götherström G, Sunnerhagen K, Bengtsson B-Å, Johannsson G 2001 Baseline characteristics and the effects of five years of growth hormone (GH) replacement therapy in adults with GH deficiency of childhood or adulthood onset; a comparative, prospective study. J Clin Endocrinol Metab 86:4693-4699
12. Monson JP, Abs R, Bengtsson B-Å, Bennmarker H, Feldt-Rasmussen U, Hernberg-Stahl E, Thoren M, Westberg B, Wilton P, Wüster C 2000 Growth hormone deficiency and replacement in elderly hypopituitary adults. KIMS Study Group and the KIMS International Board. Pharmacia and Upjohn International Metabolic Database. Clin Endocrinol (Oxf) 53:281-289
13. Elgzyri T, Castenfors J, Hagg E, Backman C, Thorén M, Bramnert M 2004 The effects of GH replacement therapy on cardiac morphology and function, exercise capacity and serum lipids in elderly patients with GH deficiency. Clin Endocrinol (Oxf) 61:113-122
14. Feldt-Rasmussen U, Wilton P, Jonsson P 2004 Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults. Growth Horm IGF Res 14 (Suppl A):S51-S58
15. Götherström G, Bengtsson B-Å, Sunnerhagen K, Johannsson G, Svensson J 2005 The effects of five-year growth hormone replacement therapy on muscle strength in elderly hypopituitary adults. Clin Endocrinol (Oxf) 62:105-113
16. Johannsson G, Rosén T, Bengtsson B-Å 1997 Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults. Clin Endocrinol (Oxf) 47:571-581
17. Landin-Wilhelmsen K, Wilhelmsen L, Lappas G, Rosén T, Lindstedt G, Lundberg P, Bengtsson B-Å 1994 Serum insulin-like growth factor I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clin Endocrinol (Oxf) 41:351-357
18. Mazess R, Barden H, Bisek J, Hanson J 1990 Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr 51:1106-1112
19. Bruce Å, Andersson M, Arvidsson B, Isaksson B 1980 Body composition. Prediction of normal body potassium, body water and body fat in adults on the basis of body height, body weight and age. Scand J Clin Lab Invest 40:461-473
20. Svensson J, Johannsson G, Bengtsson B-Å 1997 Insulin-like growth factor-I in growth hormone-deficient adults: relationship to population-based normal values, body composition and insulin tolerance test. Clin Endocrinol (Oxf) 46:579-586
21. Wiklund O, Fager G, Craigh I, Wilhelmsson C, Vedin A, Olofsson S, Bondjers G, Wilhelmsen L 1980 α-Lipoprotein cholesterol in relation to acute myocardial infarction and its risk factors. Scand J Clin Lab Invest 40:239-247
22. Friedewald W, Levy R, Fredrickson D 1972 Estimation of low-density lipoprotein in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502
23. Shalet S, Toogood A, Rahim A, Brennan B 1998 The diagnosis of growth hormone deficiency in children and adults. Endocr Rev 19:203-223
24. Ohlsson C, Bengtsson B-Å, Isaksson O, Andreassen T, Slootweg M 1998 Growth hormone and bone. Endocr Rev 19:55-79
25. Wüster C, Slenczka E, Ziegler R 1991 Increased prevalence of osteoporosis and arteriosclerosis in conventionally substituted anterior pituitary insufficiency: need for additional growth hormone substitution? Klinische Wochenschrift 69:769-773
26. Rosén T, Wilhelmsen L, Landin-Wilhelmsen K, Lappas G, Bengtsson B-Å 1997 Increased fracture frequency in adult patients with hypopituitarism and GH deficiency. Eur J Endocrinol 137:240-245
27. Wüster C, Abs R, Bengtsson B-Å, Bennmarker H, Feldt-Rasmussen U, Hernberg-Stahl E, Monson JP, Westberg B, Wilton P 2001 The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. J Bone Miner Res 16:398-405
28. Heart Protection Study Collaborative Group 2002 MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360:7-22
29. Blackman M, Sorkin JD, Munzer T, Bellantoni M, Busby-Whitehead J, Stevens T, Jayme J, O'Connor K, Christmas C, Tobin J, Stewart K, Cottrell E, St Clair C, Pabst K, Harman S 2002 Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. JAMA 288:2282-2292
30. Lange K, Andersen J, Beyer N, Isaksson F, Larsson B, Rasmussen M, Juul A, Bulow J, Kjaer M 2002 GH administration changes myosin heavy chain isoforms in skeletal muscle but does not augment muscle strength or hypertrophy, either alone or combined with resistance exercise training in healthy elderly men. J Clin Endocrinol Metab 87:513-523